Grant of Waiver for further delay in despatch of circular under rule 14.41(a) of the listing rules
Filed with HKEX · Stock code 1312 · · 2 pages · English
Kontafarma China Holdings Ltd on 6ix
Earlier from Kontafarma China
- Kontafarma China Appoints Wang Limin As Executive Director, Chairman And President
- Kontafarma China Announces Resignation Of Liu Jiankun As Executive Director Effective 16 Apr
- Kontafarma China Posts Loss For Year Attributable HKD 427.8 Million
- Kontafarma China Expects FY2025 Consolidated Net Loss Of HK$414.1 Million-HK$506.2 Million
- Kontafarma China Says Qiao Linna Resigns As Executive Director, Vice President
Later from Kontafarma China
- Major transaction in relation to renewal of lease for fitness and yoga centre
- MAJOR TRANSACTION (Multi-Files)
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30th September, 2026
Follow Kontafarma China into a list and get an email when it puts out news.
Follow Kontafarma China